Tecentriq 1,200 MG/20 ML vial 20ML
Ended Awarded
- Contract number
- SPE2DB26FNMNM
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $6,503
Award facts
- Contract value 100% obligated
- $6,502.99 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Tecentriq (1,200 mg/20 mL vial) valued at $6,502.99 with a firm fixed-price structure. The delivery order was awarded on November 4, 2025, with an ultimate completion date of November 26, 2025, and carries no set-aside designation. DMS Pharmaceutical Group Inc. is fulfilling this order under its single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, which was awarded on November 13, 2025, with a $499.999 billion ceiling value and completion date of December 31, 2036.
As a critical supplier within the Department of Defense pharmaceutical supply chain, DMS Pharmaceutical Group leverages its small business status to distribute a comprehensive range of pharmaceuticals and medical consumables to federal military healthcare facilities worldwide. Tecentriq, an oncology treatment, represents one of numerous branded specialty pharmaceuticals and biologics the company supplies through the PPV-G GEN V contract, which positions DMS as a regional prime vendor contractor within the broader $30.3 billion acquisition strategy designed to support recurring medical supply needs across the military healthcare system. The company maintains no identified subcontractor relationships and has demonstrated substantial federal contracting activity through consistent performance on multiple delivery orders issued by the Defense Logistics Agency's Medical Supply Chain division.
Quick answers
Who was awarded contract SPE2DB26FNMNM?
SPE2DB26FNMNM was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on November 4, 2025.
How much is contract SPE2DB26FNMNM worth?
The government has obligated $6,503 on SPE2DB26FNMNM.
Is contract SPE2DB26FNMNM an order under another contract?
Yes. SPE2DB26FNMNM is a delivery order under SPE2DB25D9348, an indefinite delivery contract.
Was contract SPE2DB26FNMNM competed?
The extent of competition for SPE2DB26FNMNM was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award